Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin as add-on to liraglutide and insulin in type 1 diabetes
NCT02518945Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in type 1 diabetes mellitus (T1D), sponsored by University at Buffalo. Started Aug 2015; status: completed.
02
Drugs
dapagliflozin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02518945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02518945.